Healthpeak Properties is trading at historically low valuations, offering a compelling 7% dividend yield with strong coverage and solid operating results. The REIT's diversified portfolio, consistent NOI growth, and defensive healthcare focus provide stability and resilience against macroeconomic shocks. Insider buying and share repurchases signal management's confidence in the stock's undervaluation and future upside potential.
Founded in 1869, Goldman Sachs is the world's second-largest investment bank by revenue and is ranked 55th on the Fortune 500 list of the largest U.S.
A dividend stock with 7%-plus yields and solid upside potential. The downside risk is also limited at current prices.
Fifteen years of investing and writing taught me that humility, perseverance, and financial literacy are essential for long-term success. Avoid market timing and emotional investing; focus on time in the market, sound fundamentals, and disciplined research-based decisions. Steer clear of high-yield, speculative REITs; prioritize blue-chip REITs with reliable income and growth prospects for wealth building.
Dividend stocks are worth loading up on, as significant uncertainty is still ahead.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
DOC's Q1 results reflect the continued strong performance of its high-quality lab, outpatient medical and CCRC portfolios.
The headline numbers for Healthpeak (DOC) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Healthpeak (DOC) came out with quarterly funds from operations (FFO) of $0.46 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.45 per share a year ago.
DOC's Q1 earnings are likely to have benefited from rising healthcare spending and the aging population. However, higher interest expenses may have hurt it.
Get a deeper insight into the potential performance of Healthpeak (DOC) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Healthpeak Properties is a high-quality healthcare REIT trading at a low valuation, offering 25-30% price appreciation and a ~6.7% annual dividend yield. The successful merger with Physicians Realty Trust has created a dominant healthcare REIT with significant synergies, improving operational performance and tenant diversification. Healthpeak's portfolio benefits from a strong demographic tailwind, robust leasing activity, and strategic focus on outpatient medical buildings and life science properties.